Micrologix Biotech Inc. (MGIXF) Third Quarter Results Conference Call & Web Cast Notification 
10/19/2005 5:10:21 PM

VANCOUVER, March 8 /PRNewswire-FirstCall/ -- Micrologix Biotech Inc. (TSX: MBI; OTC: MGIXF) will host a conference call and web cast on Thursday, March 11, 2004 at 9:00 a.m. ET (6:00 a.m. PT) to discuss financial results for the third quarter ended January 31, 2004 and provide an update on company activities. To participate in the conference call, please dial 416-405-9310 or

1-877-211-7911. The call will be available for replay until March 25, 2004 by calling 1-800-408-3053 or 416-695-5800 and entering the pass code 3009242. The live and archived web cast can be accessed through the company's website at

About Micrologix

Micrologix Biotech Inc. is engaged in the research, development, and commercialization of drugs that advance therapy, improve health, and enrich lives. The Company's focus is toward anti-infective drug development with four product candidates in human clinical development, multiple product opportunities in preclinical development, and several early-stage technologies in various stages of research and evaluation.

Micrologix Biotech Inc.

CONTACT: Investor & Media Relations Contacts: JonathanBurke, Micrologix Biotech Inc., Telephone: (604) 221-9666 Extension 241,Email:; Gino de Jesus or Dian Griesel, Ph.D, TheInvestor Relations Group, Telephone: (212) 825-3210,;To request a free copy of this organization's annual report, please go to and click on reports@cnw.